1. Home
  2. RCKT vs OLO Comparison

RCKT vs OLO Comparison

Compare RCKT & OLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • OLO
  • Stock Information
  • Founded
  • RCKT 1999
  • OLO 2005
  • Country
  • RCKT United States
  • OLO United States
  • Employees
  • RCKT N/A
  • OLO N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • OLO Major Banks
  • Sector
  • RCKT Health Care
  • OLO Finance
  • Exchange
  • RCKT Nasdaq
  • OLO Nasdaq
  • Market Cap
  • RCKT 764.5M
  • OLO 1.0B
  • IPO Year
  • RCKT N/A
  • OLO 2021
  • Fundamental
  • Price
  • RCKT $7.18
  • OLO $8.05
  • Analyst Decision
  • RCKT Strong Buy
  • OLO Buy
  • Analyst Count
  • RCKT 10
  • OLO 3
  • Target Price
  • RCKT $44.10
  • OLO $8.67
  • AVG Volume (30 Days)
  • RCKT 3.2M
  • OLO 1.5M
  • Earning Date
  • RCKT 05-08-2025
  • OLO 05-08-2025
  • Dividend Yield
  • RCKT N/A
  • OLO N/A
  • EPS Growth
  • RCKT N/A
  • OLO N/A
  • EPS
  • RCKT N/A
  • OLO N/A
  • Revenue
  • RCKT N/A
  • OLO $284,938,000.00
  • Revenue This Year
  • RCKT N/A
  • OLO $18.70
  • Revenue Next Year
  • RCKT N/A
  • OLO $18.20
  • P/E Ratio
  • RCKT N/A
  • OLO N/A
  • Revenue Growth
  • RCKT N/A
  • OLO 24.82
  • 52 Week Low
  • RCKT $4.55
  • OLO $4.20
  • 52 Week High
  • RCKT $26.98
  • OLO $8.35
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 46.92
  • OLO 80.38
  • Support Level
  • RCKT $6.21
  • OLO $6.99
  • Resistance Level
  • RCKT $8.26
  • OLO $6.39
  • Average True Range (ATR)
  • RCKT 0.58
  • OLO 0.26
  • MACD
  • RCKT 0.03
  • OLO 0.20
  • Stochastic Oscillator
  • RCKT 28.05
  • OLO 94.85

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About OLO Olo Inc.

Olo Inc is an open Software as a Service platform for restaurants. Its platform powers restaurant brands' on-demand digital commerce operations, enabling digital ordering, delivery, front-of-house management, and payments, while further strengthening and enhancing restaurants' direct guest relationships. The company generates revenue from providing its customers access to its platform.

Share on Social Networks: